Addyi is a prescription medication used to treat low sexual desire in women, a condition formally called hypoactive sexual desire disorder (HSDD). It was the first drug approved by the FDA specifically for this purpose. Addyi is taken as a daily pill at bedtime, and most women need at least four to eight weeks before noticing a difference.
What HSDD Actually Means
HSDD isn’t just a temporary dip in interest. It’s a persistent, distressing loss of sexual desire that isn’t explained by another medical condition, a relationship problem, medication side effects, or a mental health disorder. The key word is “distressing”: if low desire doesn’t bother you, it’s not HSDD. The condition is surprisingly common, affecting an estimated one in ten women at some point.
Addyi was originally studied and approved for premenopausal women, though clinical trials have also included postmenopausal women under 65. It is not designed for men, and it is not intended to boost sexual performance or treat arousal problems. Its target is specifically desire, the mental component of wanting sexual activity in the first place.
How Addyi Works in the Brain
Unlike drugs for erectile dysfunction, which increase blood flow, Addyi works on brain chemistry. It adjusts the balance between neurotransmitters that promote sexual desire and one that can suppress it. Specifically, it increases levels of dopamine and norepinephrine, both of which play excitatory roles in motivation and arousal, while lowering serotonin activity in certain brain regions involved in sexual response.
Serotonin is often thought of as a “feel-good” chemical, but it actually has an inhibitory effect on sexual desire. Addyi activates one type of serotonin receptor while blocking another, which produces a net decrease in serotonin signaling in areas like the prefrontal cortex and hypothalamus. The result is a shift in the brain’s neurochemical balance that, over time, can restore some degree of sexual interest. This is why Addyi needs to be taken daily rather than on demand: it gradually recalibrates brain chemistry rather than producing an immediate effect.
How Effective Is Addyi?
Addyi’s effectiveness is real but modest. In a pooled analysis of eight randomized trials, women taking Addyi reported about 0.5 additional satisfying sexual experiences per month compared to women taking a placebo. That’s roughly one extra satisfying encounter every two months on average.
That number has been a source of debate since the drug’s approval. Critics argue the benefit is too small to justify the side effects, while supporters point out that clinical trial averages obscure the range of individual responses. Some women experience a meaningful improvement in desire and satisfaction; others notice little change. The general recommendation is to try the medication for eight weeks. Some women see results as early as four weeks, but if nothing has changed by the eight-week mark, it’s reasonable to stop.
How It’s Taken
Addyi is a 100 mg tablet taken once daily at bedtime, and the timing matters. Taking it during waking hours significantly raises the risk of a sudden drop in blood pressure, fainting, drowsiness, and accidental injury. By taking it right before sleep, these effects occur while you’re already lying down and are far less dangerous.
This isn’t a medication you take before sex. It works through daily, continuous use, slowly shifting brain chemistry over weeks. Missing doses or taking it sporadically won’t produce results.
Common Side Effects
The most frequently reported side effects in clinical trials of premenopausal women were:
- Dizziness: 11.4% of women
- Sleepiness: 11.2%
- Nausea: 10.4%
- Fatigue: 9.2%
Postmenopausal women in trials experienced these same side effects at somewhat lower rates, ranging from 3% to about 8%. For most women, these effects are mild and tend to lessen over the first few weeks of treatment. Taking the pill at bedtime helps, since you’ll sleep through the peak drowsiness period.
Alcohol and Drug Interactions
One of the most important safety concerns with Addyi is its interaction with alcohol. Drinking while taking Addyi can cause a dangerous drop in blood pressure and increase the risk of fainting. This interaction was serious enough that the FDA originally required a boxed warning, the strongest type of safety alert on a prescription drug label.
Addyi is also processed by a specific liver enzyme. Medications that block this enzyme, including certain antifungals, some antibiotics, and HIV medications, can cause Addyi to build up to unsafe levels in the body. Women with liver impairment should not take it, since the drug won’t be cleared properly. If you’re on other medications, your prescriber will need to check for interactions before starting Addyi.
How Addyi Compares to Vyleesi
Addyi isn’t the only FDA-approved option for HSDD. Vyleesi, approved in 2019, treats the same condition but works very differently in practice. While Addyi is a daily pill that takes weeks to build up, Vyleesi is an injection you self-administer in the thigh or abdomen about 45 minutes before anticipated sexual activity. It works through a completely different pathway, activating receptors involved in the body’s stress and arousal response.
The choice between the two comes down to lifestyle and preference. Some women prefer the consistency of a daily pill and don’t want to plan around sexual activity. Others prefer an on-demand option and are comfortable with self-injection. Nausea is a common side effect of both medications, though the patterns differ: with Addyi it can be ongoing, while with Vyleesi it tends to occur around the time of each injection. Neither medication is dramatically more effective than the other in clinical trials, so the decision is often practical rather than medical.